Atlas Trials

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

Clinical trial NCT00758199 · COMPLETED

Trial details

NCT number
NCT00758199
Sponsor
Bp Consulting, Inc
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cataracts
Start date
2008-07-01
Primary completion
2010-01-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.